Duprey Lauren Rusckowski

SEC Form 4 insider

Chief Transformation Officer · TAKEDA PHARMACEUTICAL CO LTD ($TAK)

2 theses · first seen Aug 13, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	1	1	1	100%	-0.1%	-0.1%
3d	1	1	0	0%	+1.3%	+1.3%
1w	1	1	0	0%	+5.3%	+5.3%
1m	1	1	0	0%	+4.9%	+4.9%
3m	0	0	0	—	—	—
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TAKSEC Form 4bearish

Duprey Lauren Rusckowski · Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD · 15d ago1 prior · awaiting results

Sold 34,535 @ $18.54 avg · $640,279 · 2026-09-14

Form 4: Duprey Lauren Rusckowski sold TAK

Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 34,535 shares of TAK at an average $18.54, roughly $640,279, in a Form 4 filed 2026-09-15.

At post $18.70Now $18.91+1.1% since postedas of Sep 18, 4:31 PM ET

1d-0.3%

3d+1.1%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$TAKSEC Form 4bearish

Duprey Lauren Rusckowski · Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD · 49d ago1 prior · awaiting results

Sold 47,586 @ $17.10 avg · $813,721 · 2026-08-10

Form 4: Duprey Lauren Rusckowski sold TAK

Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 47,586 shares of TAK at an average $17.10, roughly $813,721, in a Form 4 filed 2026-08-12.

At post $17.41Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET

1d-0.1%

3d+1.3%

1w+5.3%

1m+4.9%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.